Why Venture Capital Just Dumped $1 Billion Into IM8 Health (David Beckham’s Supplement Brand)

The wellness CPG space was just rocked by a massive headline: Prenetics announced that its supplement brand, IM8 Health (co-founded with David Beckham), secured a staggering $1 billion non-dilutive growth financing commitment from venture capital titan General Catalyst. But behind the gaudy headlines lies a complex financial mechanism that could either change wellness CPG forever. In this video, I'm breaking down the reality of General Catalyst’s Customer Value Fund, unpacking the mechanics of cohort financing, and exposing the silent operational risks known as "Growth Trap Over-Optimization."Is Prenetics executing a brilliant sprint to a Big CPG acquisition, or are they walking into another corporate strategy nightmare? Let's look past the spreadsheet illusion.Additionally, I'll cover key topics like:Prenetics' strategic detour and divestiture of Europa Sports ProductsHow General Catalyst’s CVF funds up to 70% of digital marketing spend without equity dilutionWhy software scales effortlessly but physical consumer packaged goods do notHow global CPG giants like Unilever or Nestlé unroll internet-famous brands and fix "cost problems"